lobbying_filings_raw: 9d65d710-4644-4d36-8eef-57ce6ac00a1c
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json | registrant_state | registrant_country | registrant_house_id | client_state | client_ppb_state | client_country | client_ppb_country | client_general_description | client_government_entity | affiliated_org_count | client_entity_id | client_government_unit_id | client_match_method | client_match_confidence |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9d65d710-4644-4d36-8eef-57ce6ac00a1c | Q1 | 7053 | BRISTOL-MYERS SQUIBB COMPANY | 109642 | BRISTOL-MYERS SQUIBB COMPANY | 2018 | first_quarter | 2018-04-18T18:34:41.057000-04:00 | 800000.0 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/9d65d710-4644-4d36-8eef-57ce6ac00a1c/", "filing_uuid": "9d65d710-4644-4d36-8eef-57ce6ac00a1c", "filing_type": "Q1", "filing_type_display": "1st Quarter - Report", "filing_year": 2018, "filing_period": "first_quarter", "filing_period_display": "1st Quarter (Jan 1 - Mar 31)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/9d65d710-4644-4d36-8eef-57ce6ac00a1c/print/", "filing_document_content_type": "text/html", "income": null, "expenses": "800000.00", "expenses_method": "a", "expenses_method_display": "Method A - Reporting amounts using LDA definitions only", "posted_by_name": "Chris Pernie", "dt_posted": "2018-04-18T18:34:41.057000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "801 Pennsylvania Ave, NW, Suite 325", "registrant_address_2": null, "registrant_different_address": false, "registrant_city": "WASHINGTON", "registrant_state": "DC", "registrant_zip": "20004", "registrant": {"id": 7053, "url": "https://lda.senate.gov/api/v1/registrants/7053/", "house_registrant_id": 31580, "name": "BRISTOL-MYERS SQUIBB COMPANY", "description": "Lobbying on biopharmaceutical issues.", "address_1": "801 Pennsylvania Ave, NW, Suite 745", "address_2": null, "address_3": null, "address_4": null, "city": "WASHINGTON", "state": "DC", "state_display": "District of Columbia", "zip": "20004", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "LAURA DAVIS EIDSON", "contact_telephone": "+1 727-519-5721", "dt_updated": "2026-01-30T12:07:02.522051-05:00"}, "client": {"id": 109642, "url": "https://lda.senate.gov/api/v1/clients/109642/", "client_id": 12, "name": "BRISTOL-MYERS SQUIBB COMPANY", "general_description": null, "client_government_entity": false, "client_self_select": true, "state": "DC", "state_display": "District of Columbia", "country": "US", "country_display": "United States of America", "ppb_state": "DC", "ppb_state_display": "District of Columbia", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2013-05-21"}, "lobbying_activities": [{"general_issue_code": "TRD", "general_issue_code_display": "Trade (domestic/foreign)", "description": "Lobbied regarding intellectual property rights in trade agreements and international negotiations.\nSaudi Arabia, Saudi Food and Drug Authority, lobbied Congress regarding pharmaceutical patent infringement issues.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 138136, "prefix": "mr", "prefix_display": "MR.", "first_name": "PAUL", "nickname": null, "middle_name": "ANTHONY", "last_name": "WILLIAMS", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 39456, "prefix": null, "prefix_display": null, "first_name": "CHRISTOPHER", "nickname": null, "middle_name": null, "last_name": "PERNIE", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 36053, "prefix": null, "prefix_display": null, "first_name": "LANE", "nickname": null, "middle_name": null, "last_name": "PENRY", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 24, "name": "Commerce, Dept of (DOC)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 137, "name": "Health Resources & Services Administration (HRSA)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}, {"id": 22, "name": "U.S. Trade Representative (USTR)"}]}, {"general_issue_code": "TAX", "general_issue_code_display": "Taxation/Internal Revenue Code", "description": "H.R. 1, Tax Cuts and Jobs Act, regarding all pharmaceutical related provisions.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 138136, "prefix": "mr", "prefix_display": "MR.", "first_name": "PAUL", "nickname": null, "middle_name": "ANTHONY", "last_name": "WILLIAMS", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 39456, "prefix": null, "prefix_display": null, "first_name": "CHRISTOPHER", "nickname": null, "middle_name": null, "last_name": "PERNIE", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 36053, "prefix": null, "prefix_display": null, "first_name": "LANE", "nickname": null, "middle_name": null, "last_name": "PENRY", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 24, "name": "Commerce, Dept of (DOC)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 137, "name": "Health Resources & Services Administration (HRSA)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}, {"id": 22, "name": "U.S. Trade Representative (USTR)"}]}, {"general_issue_code": "CPT", "general_issue_code_display": "Copyright/Patent/Trademark", "description": "No bill, lobbied on patent troll issues regarding biopharmaceutical patents.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 138136, "prefix": "mr", "prefix_display": "MR.", "first_name": "PAUL", "nickname": null, "middle_name": "ANTHONY", "last_name": "WILLIAMS", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 36053, "prefix": null, "prefix_display": null, "first_name": "LANE", "nickname": null, "middle_name": null, "last_name": "PENRY", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 39456, "prefix": null, "prefix_display": null, "first_name": "CHRISTOPHER", "nickname": null, "middle_name": null, "last_name": "PERNIE", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 24, "name": "Commerce, Dept of (DOC)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 137, "name": "Health Resources & Services Administration (HRSA)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}, {"id": 22, "name": "U.S. Trade Representative (USTR)"}]}, {"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "No bill, lobbied to raise awareness about Atrial Fibrillation and stroke prevention.\nNo bill, lobbied regarding biosimilars issues including naming, labeling and interchangeability.\nH.R. 1245 and S. 469, Affordable and Safe Prescription Drug Importation Act, lobbied regarding all biopharmaceutical provisions.\nH.R. 1703, Medical Product Communications Act of 2017, regarding all biopharmaceutical related provisions\nH.R. 2851, Stop the Importation and Trafficking of Synthetic Analogues Act of 2017, regarding all biopharmaceutical related provisions\nNo bill, lobbied for changes to the 340B Drug Discount Program.\nH.R. 4710, 340B PAUSE Act, lobbied regarding all biopharmaceutical provisions.\nH.R. 4392, a bill to repeal the HOPPS final regulation related to changes in the payment amount for certain drugs under the 340B program, lobbied regarding all biopharmaceutical provisions.\nH.R. 2026, the Pharmaceutical Information Exchange (PIE) Act of 2017, lobbied regarding all biopharmaceutical provisions.\nS. 2312, Helping Ensure Low-Income Patients have Access to Care and Treatment (HELP) Act, regarding all pharmaceutical related provisions.\nS.2453, Ensuring the Value of the 340B Program Act of 2018, regarding all pharmaceutical related provisions.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 138136, "prefix": "mr", "prefix_display": "MR.", "first_name": "PAUL", "nickname": null, "middle_name": "ANTHONY", "last_name": "WILLIAMS", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 39456, "prefix": null, "prefix_display": null, "first_name": "CHRISTOPHER", "nickname": null, "middle_name": null, "last_name": "PERNIE", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 36053, "prefix": null, "prefix_display": null, "first_name": "LANE", "nickname": null, "middle_name": null, "last_name": "PENRY", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 24, "name": "Commerce, Dept of (DOC)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 137, "name": "Health Resources & Services Administration (HRSA)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}, {"id": 22, "name": "U.S. Trade Representative (USTR)"}]}, {"general_issue_code": "MMM", "general_issue_code_display": "Medicare/Medicaid", "description": "H.R. 849, S. 260, S. 251 Protecting Seniors Access to Medicare Act, lobbied regarding all biopharmaceutical related provisions.\nS.771, Improving Access To Affordable Prescription Drugs Act, lobbied regarding all biopharmaceutical related provisions. \nS.348, Prescription Drug and Health Improvement Act of 2017, lobbied regarding all biopharmaceutical related provisions.\nS.637, Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017, lobbied regarding all biopharmaceutical related provisions.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 138136, "prefix": "mr", "prefix_display": "MR.", "first_name": "PAUL", "nickname": null, "middle_name": "ANTHONY", "last_name": "WILLIAMS", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 39456, "prefix": null, "prefix_display": null, "first_name": "CHRISTOPHER", "nickname": null, "middle_name": null, "last_name": "PERNIE", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 36053, "prefix": null, "prefix_display": null, "first_name": "LANE", "nickname": null, "middle_name": null, "last_name": "PENRY", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 24, "name": "Commerce, Dept of (DOC)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 137, "name": "Health Resources & Services Administration (HRSA)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}, {"id": 22, "name": "U.S. Trade Representative (USTR)"}]}, {"general_issue_code": "BUD", "general_issue_code_display": "Budget/Appropriations", "description": "American Health Care Act, regarding all biopharmaceutical related provisions.\nContinuing Budget Resolution, lobbied regarding all biopharmaceutical provisions.\nBetter Care Reconciliation Act, regarding all biopharmaceutical related provisions.\nS. 1771, Department of Labor, HHS and Education Appropriations Act, regarding all pharmaceutical related provisions.\nH.R. 1625, Consolidates Appropriations Act, regarding all pharmaceutical related provisions.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 138136, "prefix": "mr", "prefix_display": "MR.", "first_name": "PAUL", "nickname": null, "middle_name": "ANTHONY", "last_name": "WILLIAMS", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 39456, "prefix": null, "prefix_display": null, "first_name": "CHRISTOPHER", "nickname": null, "middle_name": null, "last_name": "PERNIE", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 36053, "prefix": null, "prefix_display": null, "first_name": "LANE", "nickname": null, "middle_name": null, "last_name": "PENRY", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 24, "name": "Commerce, Dept of (DOC)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 137, "name": "Health Resources & Services Administration (HRSA)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}, {"id": 22, "name": "U.S. Trade Representative (USTR)"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} | DC | US | 31580 | DC | DC | US | US | 0 | 0 | 63 | normalized_name_dc_fallback | 0.8 |